SCHEMBL29482109

SCHEMBL29482109

CN1CCO[C@@H](CNc2ccc(S(N)(=O)=O)cc2[N+](=O)[O-])C1

nearest known ligand 0.58

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.58
MEN1 O00255 2/20 0.58
MAPT P10636 9/20 0.56
PKM P14618 6/20 0.56
POLB P06746 2/20 0.51
SMN1; SMN2 Q16637 2/20 0.48
GAA P10253 2/20 0.47
LMNA P02545 6/20 0.47
ALDH1A1 P00352 3/20 0.46
TDP1 Q9NUW8 4/20 0.46
ALOX12 P18054 1/20 0.46
HCAR3 P49019 1/20 0.45
L3MBTL1 Q9Y468 3/20 0.45
HPGD P15428 1/20 0.44
MAPK1 P28482 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29424543 1.00 KMT2A (0.58) KMT2AMEN1MAPTPKMPOLB
SCHEMBL22581386 1.00 KMT2A (0.58) KMT2AMEN1MAPTPKMPOLB
SCHEMBL29424541 1.00 KMT2A (0.58) KMT2AMEN1MAPTPKMPOLB
SCHEMBL1700350 1.00 KMT2A (0.58) KMT2AMEN1MAPTPKMPOLB
SCHEMBL22581236 1.00 KMT2A (0.58) KMT2AMEN1MAPTPKMPOLB
SCHEMBL25417524 0.90 KMT2A (0.56) KMT2AMEN1MAPTPKMPOLB
SCHEMBL1700027 0.90 KMT2A (0.58) KMT2AMEN1MAPTPKMPOLB
SCHEMBL25416070 0.88 KMT2A (0.56) KMT2AMEN1MAPTPKMPOLB
SCHEMBL28845370 0.88 MAPT (0.56) KMT2AMEN1MAPTPKMPOLB
SCHEMBL1700354 0.87 MAPT (0.54) KMT2AMEN1MAPTPKMPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118084904-A Benzamide compounds 里科瑞尔姆IP控股有限责任公司 2024-05-28 CN disclosed
CN-111801327-B Benzamide compounds 里科瑞尔姆IP控股有限责任公司 2024-02-09 CN disclosed
CN-114126616-A Nanoparticle formulations of BCL-2 inhibitors 里科瑞尔姆IP控股有限责任公司 2022-03-01 CN disclosed